November 21, 2024
Seminar 21, Beyond Insulin Seminar Series – Dr Alice Long presents ‘Clues to how T cell tolerance prevents T1D progression revelated through clinical trials’
Read moreOctober 25, 2024
Seminar 20, Beyond Insulin Seminar Series – A/Prof Joshua Ooi presents ‘Antigen-specific Tregs to treat autoimmune diseases’.
Read more
August 2024
The ATIC community engagement panel and steering committee have supported the preparation of a position statement on the use of off-label baricitnib.
Read moreSeptember 26, 2024
Seminar 19, Beyond Insulin Seminar Series – A/Prof John Wentworth presents ‘Development and deployment of agglutination-PCR testing for islet autoantibodies’.
Read more
July 2024
A group of ATIC clinician-researchers with support from JDRFA have published the Australian guidelines “Care pathways for people with early-stage type 1 diabetes in Australia”.
Read moreJuly 25, 2024
Seminar 18, Beyond Insulin Seminar Series – Dr Kirstine Bell presents ‘Making a National Screening Program for Type 1 Diabetes a Reality in Australia: Progress and Plans’
Read moreMay 23, 2024
Seminar 16, Beyond Insulin Seminar Series – Dr Elizabeth Holmes-Truscott present ‘Measuring what matters: the assessment of psychosocial and behavioural outcomes in type 1 diabetes trials’.
Read moreJune 28, 2024
Seminar 17, Beyond Insulin Seminar Series – Professor Ranjeny Thomas talk about ‘clinical translation of antigen-specific immunotherapy for type 1 diabetes’.
Read moreApril 26, 2024
Seminar 15, Beyond Insulin Seminar Series – Dr Shivani Patel from the Garvan Institute of Medical Research will present ‘PANDA (Pan autoantibody negative diabetes in adults) study’.
Read moreMarch 28, 2024
Seminar 14, Beyond Insulin Seminar Series – Associate Professor Jason Tye-Din from WEHI will present ‘Lessons from a failed coeliac disease trial: a new way forwards?’
Read moreFebruary 23, 2024
Seminar 13, Beyond Insulin Seminar Series – Dr Maria Redondo from Baylor College of Medicine, Houston, Texas provides an update on T1D Genetic Risk Scores in T1D
Read moreNovember 23, 2023
December 2023
In a world-first, ATIC researchers lead by Professor’s Thomas Kay and Helen Thomas have shown that baricitinib, an immunotherapy treatment commonly used in rheumatoid arthritis, can delay the progression of type 1 diabetes…
Read moreNovember 23, 2023
Seminar 12 in the Beyond Insulin Seminar Series will be a summary of the findings from a recent discovery in CD47 receptors and type 1 diabetes by Professor Natasha Rogers (Westmead Hospital).
Read moreOctober 27, 2023
Seminar 11 – Beyond Insulin Seminar Series, Dr Linda Wu from Westmead Institute for Medical Research provides an update on current knowledge around checkpoint inhibitor related diabetes
Read more
September 2023
ATIC and The Royal Melbourne Hospital are now seeking people aged 8-45 years with recently diagnosed type 1 diabetes (within three months) for a new clinical trial of two disease-modifying medications rituximab-pvvr and abatacept, called T1D RELAY.
Read moreSeptember 21, 2023
Seminar 10 of the Beyond Insulin Seminar Series features Associate Professor Stuart Mannering who will discuss one of the fundamental outstanding questions in the immunology of T1D – how and why does the immune system attack the insulin producing cells?
Read moreJuly 27, 2023
Seminar 9 of the Beyond Insulin Seminar Series features Associate Professor Emma Hamilton-Williams. A/Prof Hamilton-Williams will discuss results from a clinical trial that aimed to restore a ‘healthy’ gut microbiota in adults with type 1 diabetes.
Read more
June 2023
For the first time in Australia, researchers will carry out a type 1 diabetes trial to test two different immune therapies in children and young adults who have been recently diagnosed with type 1 diabetes.
Read moreApril 28, 2023
7th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more
March 2023
The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.
Read moreMarch 23, 2023
6th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read moreFebruary 22, 2023
ATIC recently invited members of the type 1 diabetes community to learn more about ATIC – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments.
Read moreFebruary 24, 2023
5th seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read more
January 2023
ATIC is now seeking participants aged between 6 and 21 years with newly diagnosed type 1 diabetes for a ground-breaking Australian clinical trial.
Read more
November 2022
ATIC is seeking expressions of interest from members of the type 1 diabetes community who are interested in joining our Community Engagement Panel.
Read moreOctober 28, 2022
3rd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read moreSeptember 29, 2022
2nd seminar in the ‘Beyond Insulin: Innovative research in T1D prevention and cure’ seminar series
Read moreAugust 26, 2022
Introducing ATIC’s new seminar series ‘Beyond Insulin: Innovative research in T1D prevention and cure’. Join us for a new session each month!
Read moreAugust 10, 2022
We’re very excited to be officially launching ATIC at the upcoming ADC 2022 in Brisbane.
Read more
April 2022
Leading diabetes clinicians and researchers from across Australia gathered recently for the first meeting of the Australasian Type 1 Diabetes Immunotherapies Collaborative (ATIC) Steering Committee.
Read more
March 2022
The human immune system works every minute of every day to keep the body healthy – through constant monitoring, and by tracking and destroying pathogens, such as disease-causing bacteria and viruses.
Read more
February 2022
In collaboration with Innodia, the ATIC network is leading IMPACT, a trial of a new medication called IMCY-0098 to determine whether it can preserve pancreas function in people with newly diagnosed type 1 diabetes.
Read more
January 2022
Thanks to the generosity of the type 1 diabetes community, we have completed recruitment for the BANDIT trial.
Read more
January 2022
JDRF Australia has funded a first-of-its kind four-year collaboration, aimed at increasing the number of clinical trials available for Australians with type 1 diabetes.
Read more